An open-labe, multicenter, phase II single arm trial of osimertinib in NSCLC patients with uncommon EGFR mutation (KCSG-LU15-09)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang Eun Joo | - |
dc.date.accessioned | 2021-08-27T21:28:30Z | - |
dc.date.available | 2021-08-27T21:28:30Z | - |
dc.date.created | 2021-04-22 | - |
dc.date.issued | 2018-09-25 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/17719 | - |
dc.publisher | IASLC | - |
dc.title | An open-labe, multicenter, phase II single arm trial of osimertinib in NSCLC patients with uncommon EGFR mutation (KCSG-LU15-09) | - |
dc.title.alternative | An open-labe, multicenter, phase II single arm trial of osimertinib in NSCLC patients with uncommon EGFR mutation (KCSG-LU15-09) | - |
dc.type | Conference | - |
dc.contributor.affiliatedAuthor | Kang Eun Joo | - |
dc.identifier.bibliographicCitation | IASLC 19th World Conference on Lung Cancer | - |
dc.relation.isPartOf | IASLC 19th World Conference on Lung Cancer | - |
dc.relation.isPartOf | IASLC 19th World Conference on Lung Cancer abstract book | - |
dc.citation.title | IASLC 19th World Conference on Lung Cancer | - |
dc.citation.conferencePlace | CN | - |
dc.citation.conferenceDate | 2018-09-23 | - |
dc.type.rims | CONF | - |
dc.description.journalClass | 1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.